RxSight Inc.

NASDAQ: RXST · Real-Time Price · USD
8.46
0.24 (2.92%)
At close: Aug 15, 2025, 2:35 PM

RxSight Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
16.71M 9.69M 11.83M 24.36M
Short-Term Investments
220.52M 117.49M 93.97M 134.97M
Long-Term Investments
750K 711K 761K 811K
Other Long-Term Assets
360K 147K 767K 114K
Receivables
30.05M 20.28M 10.96M 4.86M
Inventory
22.01M 17.42M 14.84M 8.03M
Other Current Assets
4.54M 3.52M 2.96M n/a
Total Current Assets
293.82M 168.41M 134.56M 176.29M
Property-Plant & Equipment
23.63M 13.29M 14.08M 15.5M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
24.74M 14.14M 15.61M 16.43M
Total Assets
318.56M 182.55M 150.16M 192.72M
Account Payables
4.54M 3.86M 2.6M 1.69M
Deferred Revenue
3.11M 2.04M 1.35M 618K
Short-Term Debt
974K n/a 1.97M 1.53M
Other Current Liabilities
16.27M 2.56M 8.9M 5.39M
Total Current Liabilities
25.88M 20.9M 17.24M 11.08M
Long-Term Debt
n/a n/a 40.17M 39.76M
Other Long-Term Liabilities
127K 74K n/a n/a
Total Long-Term Liabilities
11.45M 1.28M 43.02M 43.4M
Total Liabilities
37.33M 22.19M 60.26M 54.48M
Total Debt
12.3M 3.01M 44.99M 44.93M
Common Stock
40K 36K 28K 27K
Retained Earnings
-622.1M -594.64M -546.03M -479.28M
Comprehensive Income
166K -5K -95K -20K
Shareholders Equity
281.24M 160.36M 89.9M 138.24M
Total Investments
220.52M 118.2M 93.97M 134.97M